You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

FOUGERA PHARMS Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for FOUGERA PHARMS, and what generic and branded alternatives to FOUGERA PHARMS drugs are available?

FOUGERA PHARMS has one hundred and five approved drugs.

Summary for FOUGERA PHARMS

US Patents:	0
Tradenames:	50
Ingredients:	42
NDAs:	105

Drugs and US Patents for FOUGERA PHARMS

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fougera Pharms	HALOBETASOL PROPIONATE	halobetasol propionate	CREAM;TOPICAL	077001-001	Dec 16, 2004	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Fougera Pharms Inc	BETAMETHASONE VALERATE	betamethasone valerate	OINTMENT;TOPICAL	018865-001	Aug 31, 1983	AB	RX	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Fougera Pharms Inc	GENTAMICIN SULFATE	gentamicin sulfate	CREAM;TOPICAL	062531-001	Jul 5, 1984		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Fougera Pharms	TYZINE	tetrahydrozoline hydrochloride	SOLUTION;NASAL	086576-002	Approved Prior to Jan 1, 1982		RX	No	Yes		⤷ Subscribe				⤷ Subscribe
Fougera Pharms	PREDNICARBATE	prednicarbate	OINTMENT;TOPICAL	077236-001	Mar 9, 2007		RX	No	Yes		⤷ Subscribe				⤷ Subscribe
Fougera Pharms Inc	ACYCLOVIR	acyclovir	OINTMENT;TOPICAL	206633-001	May 11, 2016	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for FOUGERA PHARMS

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Fougera Pharms	CUTIVATE	fluticasone propionate	LOTION;TOPICAL	021152-001	Mar 31, 2005	7,300,669	⤷ Subscribe
Fougera Pharms	TEMOVATE	clobetasol propionate	SOLUTION;TOPICAL	019966-001	Feb 22, 1990	3,721,687	⤷ Subscribe
Fougera Pharms	SOLARAZE	diclofenac sodium	GEL;TOPICAL	021005-001	Oct 16, 2000	5,792,753	⤷ Subscribe
Fougera Pharms	SOLARAZE	diclofenac sodium	GEL;TOPICAL	021005-001	Oct 16, 2000	5,985,850	⤷ Subscribe
Fougera Pharms	ACLOVATE	alclometasone dipropionate	CREAM;TOPICAL	018707-001	Dec 14, 1982	4,124,707	⤷ Subscribe
Fougera Pharms	SOLARAZE	diclofenac sodium	GEL;TOPICAL	021005-001	Oct 16, 2000	5,914,322	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for FOUGERA PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Gel	3%	➤ Subscribe	2009-12-16
➤ Subscribe	Lotion	0.05%	➤ Subscribe	2008-07-28

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.